Prestwick3_000151

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 45 USDMF, 15 CEP/COS, 5 JDMF, 6 EU WC, 1 KDMF, 16 NDC API, 1 VMF, 19 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

162 FDF Dossiers, 94 FDA Orange Book, 44 Europe, 24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 5%;3%, TABLET, COATED PARTICLES;ORAL - 333MG, TABLET, COATED PARTICLES;ORAL - 500MG, GEL;TOPICAL - 2%, GEL;TOPICAL - 5%;3%

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 15 DKSH, 1 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 12 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 16 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

46 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 28 Disintegrants & Superdisintegrants, 28 Controlled & Modified Release, 26 Direct Compression, 26 Thickeners and Stabilizers, 21 Solubilizers, 19 Granulation, 17 Topical, 13 Lubricants & Glidants, 11 Co-Processed Excipients, 10 Film Formers & Plasticizers, 9 Empty Capsules, 9 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 6 Parenteral, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Coloring Agents, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 26 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 50 Finished Drug Prices

MARKET PLACE

20 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 4 USP, 6 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50617 / DOSAGE - GEL;TOPICAL - 2%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ERYTHROMYCIN(UNII: 63937KV33D) (ERYTHROMYCIN - UNII:63937KV33D)	ERYTHROMYCIN	20mg in 1

Inactive Ingredients

Ingredient Name	E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.	McKesson Corporation	Prestium Pharma, Inc.	Renaissance Pharma, Inc.	SOLA Pharmaceuticals
ALCOHOL(3K9958V90M)
HYDROXYPROPYL CELLULOSE (1200000 WAMW)(U3JF91U133)
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE, UNSPECIFIED(9XZ8H6N6OH)

Drug Product Composition: Prestwick3_000151